Status:
COMPLETED
The Endocannabinoid System in Human Gestational Tissues in Labor
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Labor
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.
Detailed Description
This is a pilot study to determine the feasibility of identification and quantification of various components of the endocannabinoid system in the labored versus non-labored myometrium, placenta and g...
Eligibility Criteria
Inclusion
- Pregnant women ages \> 18 years old
- Pregnant women 22 weeks, 0 days through 42 weeks, 0 days gestation undergoing cesarean section
- Singleton gestation
Exclusion
- Cannabinoid use during pregnancy
- Illicit drug use during pregnancy
- Nonsteroidal anti-inflammatory drug use within 7 days of cesarean section
- Maternal comorbidities including pre-existing diabetes, pre-existing hypertension, hypertensive disorders of pregnancy (preeclampsia, eclampsia), epilepsy currently being treated with antiepileptic medication, intraamniotic infection
- Uterine abnormalities
- Fetal anomalies
- Drug use or dependency
Key Trial Info
Start Date :
January 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03752021
Start Date
January 25 2019
End Date
July 1 2019
Last Update
August 15 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novant Health Forsyth Medical Center
Winston-Salem, North Carolina, United States, 27103
2
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157